# Hypofractionated Radiotherapy for Thymic Epithelial Tumors

> **NCT06692062** · NA · RECRUITING · sponsor: **Rongrong Zhou** · enrollment: 100 (estimated)

## Conditions studied

- Thymoma and Thymic Carcinoma
- Thymoma
- Thymic Cancer
- Thymic Epithelial Tumor

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy

## Key facts

- **NCT ID:** NCT06692062
- **Lead sponsor:** Rongrong Zhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06692062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06692062, "Hypofractionated Radiotherapy for Thymic Epithelial Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06692062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*